Heron Therapeutics | HRTX - أرباح التشغيل





أرباح التشغيل تغيير تاريخ
ALKERMES USD -10.95M 100.03M 2025-12
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
Amarin USD -2.26M 564K 2025-12
ANI Pharmaceuticals USD 29.13M 6.3M 2025-12
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD 40.81M 3.3M 2025-12
Eisai JPY 20.03B 6.36B 2025-12
Emergent BioSolutions USD -218M 69.9M 2023-06
Esperion Therapeutics USD 85.23M 95.19M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
Heron Therapeutics USD 38K 3.83M 2025-12
Insmed USD -249.71M 11.64M 2025-12
Ligand Pharmaceuticals USD 158.89M 149.17M 2025-09
Merck USD -1.88B 8.12B 2026-03
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Omeros USD -35.41M 23.75M 2024-09
Pacira USD 4.62M 1.43M 2026-03
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Surmodics USD 58K 5.7M 2025-06
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Veracyte USD 24.63M 1.52M 2025-12
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03